G
G. G. Avakyan
Researcher at Russian National Research Medical University
Publications - 14
Citations - 37
G. G. Avakyan is an academic researcher from Russian National Research Medical University. The author has contributed to research in topics: Epilepsy & Internal medicine. The author has an hindex of 3, co-authored 11 publications receiving 23 citations.
Papers
More filters
Journal ArticleDOI
[A clinical-electroneuromyographic study of the efficacy of ipidacrine in patients with mononeuropathies].
G. N. Avakyan,G. G. Avakyan +1 more
TL;DR: The obtained clinical and ENMG data indicate that axamon (ipidacrine) is a unique cholinesterase inhibitor with conduction action primarily targeting on efferent (motor) fibers of the peripheral nerves.
Journal ArticleDOI
Recommendations of the Russian League Against Epilepsy (RLAE) on the use of magnetic resonance imaging in the diagnosis of epilepsy
G. N. Avakyan,D. V. Blinov,A. A. Alikhanov,E. M. Perepelova,V. A. Perepelov,S. G. Burd,A. V. Lebedeva,G. G. Avakyan +7 more
TL;DR: Recommendations of the Russian League Against Epilepsy on the use of magnetic resonance imaging in the diagnosis of epilepsy are presented and it is suggested that implementation of these recommendations in clinical practice will improve the access to high-tech medical care and optimize health care costs.
Journal ArticleDOI
Restrictions on the use of valproate in female patients of reproductive age: the updated recommendations based on recent clinical data
G. N. Avakyan,D. V. Blinov,G. G. Avakyan,E. S. Akarachkova,S. G. Burd,P. N. Vlasov,K. V. Voronkova,V. I. Guzeva,I. A. Zhidkova,E A Katunina,D. I. Korabelnikov,A. V. Lebedeva,L. V. Lipatova,E. A. Morozova,O. M. Oleinikova,I. G. Rudakova +15 more
TL;DR: The article elaborates on the evidence of teratogenic risks associated with VA and reviews documents from the regulatory authorities, which specify the measures needed to prevent the adverse effects of VA during pregnancy, and addresses the international clinical practice on the prevention of VA-associated adverse effects during pregnancy.
Journal ArticleDOI
Research and development of 2-ethyl-6-methyl-3-oxypyridine succinate nano-form for the treatment of epilepsy
TL;DR: The nano-drug reduces the number of secondary generalized clonic-tonic seizures by 7.8 times; it also reduces 10-fold the animal mortality and diminishes the seizure manifestations that occur in the interictal period of the epileptic status.
New biomolecular targets for antiepileptic drugs
TL;DR: In this article, the authors presented the classification of antiepileptic drugs for their ability to influence the processes of excitation and inhibition in the central nervous system and presented data on new antiopeleptic drugs (AEDs).